Safety and Immunogenicity of MVA.HIVA by 3 Different Routes. In AIDS Vaccine 2005 International Conference. presented at the 06/09/2005, Montreal, Quebec, Canada.. (2005).
Predictors of Agreement Between Hair Analysis and Self-Report of Drug Use. In 77th Annual Meeting of the College on Problems of Drug Dependence (CPDD). presented at the 13/06/2015, Phoenix, AZ. Retrieved from http://www.cpdd.org/. (2015).
Seroincidence of human T-lymphotropic virus type I infection and characterization of seroconverters in Jamaican food handlers. J Acquir Immune Defic Syndr, 33(3), 387-92. presented at the 2003 Jul 01. doi:10.1097/00126334-200307010-00014. (2003).
Seroincidence of HTLV-I infection and characterization of seroconverters in Jamaican food handlers. J Acquir Immune Defic Syndr, 33, 387-392. presented at the 2003.. (2003).
Evaluation of Predictive Markers of HTLV-I Associated Disease in Jamaica. In The 12th International Conference on Human Retrovirology: HTLV and Related Viruses. presented at the 22/06/2005, Montego Bay, Jamaica. Retrieved from http://htlv.net/conferences/12th-conference. (2005).
Outcome of renal transplantation for Wilms' tumor and Denys-Drash syndrome: a report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Transplant, 9(3), 305-10. presented at the 2005 Jun. doi:10.1111/j.1399-3046.2005.00311.x. (2005).
Outcome of Renal Transplantation for Wilms' Tumor and Denys-Drash Syndrome: A Report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Transplant, 9, 305-310. presented at the 06/2005. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/15910385. (2005).
Safety evaluation of nonoxynol-9 gel in women at low risk of HIV infection. AIDS, 12(4), 433-7. presented at the 1998 Mar 05. doi:10.1097/00002030-199804000-00013. (1998).
Safety evaluation of nonoxynol-9 gel in women at low risk of HIV infection. AIDS, 12, 433-7. presented at the 1998.. (1998).
A Deep Phenotype Association Study Reveals Specific Phenotype Associations with Genetic Variants in Age-related Macular Degeneration: Age-Related Eye Disease Study 2 (AREDS2) Report No. 14. Ophthalmology, 125(4), 559-568. presented at the 2018 04. doi:10.1016/j.ophtha.2017.09.023. (2018).
No CFH or ARMS2 Interaction with Omega-3 Fatty Acids, Low versus High Zinc, or β-Carotene versus Lutein and Zeaxanthin on Progression of Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report No.. Ophthalmology, 126(11), 1541-1548. presented at the 2019 11. doi:10.1016/j.ophtha.2019.06.004. (2019).
Donor and recipient plasma follistatin levels are associated with acute GvHD in Blood and Marrow Transplant Clinical Trials Network 0402. Bone Marrow Transplant, 53(1), 64-68. presented at the 2018 01. doi:10.1038/bmt.2017.236. (2018).
A multicentre randomised double masked clinical trial of a new formulation of topical cysteamine for the treatment of corneal cystine crystals in cystinosis. Br J Ophthalmol, 87(1), 28-31. presented at the 2003 Jan. doi:10.1136/bjo.87.1.28. (2003).
A multicenter randomized double-masked clinical trial of a new formulation of topical Cysteamine for the treatment of Corneal Cystine Crystals in cystinosis. Brit J Ophthalmol, 87, 28-31. presented at the 2003.. (2003).
Metabolic and monetary costs of avoidable parenteral nutrition use. JPEN J Parenter Enteral Nutr, 23(2), 109-13. presented at the 1999 Mar-Apr. doi:10.1177/0148607199023002109. (1999).
Metabolic and monetary costs of avoidable parenteral nutritional use. J Parenter Enteral Nutr, 23, 109-13. presented at the 1999.. (1999).
Sex difference in immune response to vaccination: A participant-level meta-analysis of randomized trials of IMVAMUNE smallpox vaccine. Vaccine, 33(41), 5425-5431. presented at the 2015 Oct 05. doi:10.1016/j.vaccine.2015.08.032. (2015).
Myelodysplastic Syndromes in the United States: An Update for Clinicians. Ann Med, 46, 283-289. presented at the 08/2014. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/24716735. (2014).
Myelodysplastic syndromes in the United States: an update for clinicians. Ann Med, 46(5), 283-9. presented at the 2014 Aug. doi:10.3109/07853890.2014.898863. (2014).
Prenatal Practice Staff Perceptions of Three Substance Use Screening Tools for Pregnant Women. J Addict Med, 14(2), 139-144. presented at the 2020 Mar/Apr. doi:10.1097/ADM.0000000000000543. (2020).
Stimulant Reduction Intervention Using Dosed Exercise (STRIDE) - CTN 0037: Study Protocol for a Randomized Controlled Trial. Trials, 19, 206-231. presented at the 09/2011. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/21929768. (2011).
Stimulant reduction intervention using dosed exercise (STRIDE) - CTN 0037: study protocol for a randomized controlled trial. Trials, 12, 206. presented at the 2011 Sep 19. doi:10.1186/1745-6215-12-206. (2011).
Clinical trials referral resource. Health-related quality of life in cancer clinical trials. Oncology (Williston Park), 15(5), 601-3, 606-8, 611. presented at the 2001 May.. (2001).
Clinical trials referral resource. Current clinical trials in endometrial cancer. Oncology (Williston Park), 14(6), 850, 855, 859. presented at the 2000 Jun.. (2000).
Clinical trials referral resource. Current clinical trails in endometrial cancer. Oncology (Williston Park), 17(2), 238-40, 244, 249. presented at the 2003 Feb.. (2003).